CHAMPION HEALTHCARE CORP /TX/
8-K/A, 1995-08-07
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: AMERICAN BANCORP INC/LA, 10-Q, 1995-08-07
Next: CHAMPION HEALTHCARE CORP /TX/, 8-K/A, 1995-08-07



<PAGE>   1

                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                  FORM 8-K/A

                               AMENDMENT NO. 2

                                CURRENT REPORT

                     PURSUANT TO SECTIONS 13 OR 15(d) OF
                     THE SECURITIES EXCHANGE ACT OF 1934

      DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) DECEMBER 6, 1994

                        COMMISSION FILE NUMBER 0-11851

                       CHAMPION HEALTHCARE CORPORATION
--------------------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)

          Delaware                      0-11851                 59-2283872
--------------------------------------------------------------------------------
(State or other jurisdiction of      (Commission             (I.R.S. Employer
 incorporation or organization)      File Number)         Identification Number)

14340 Torrey Chase, Suite 320, Houston, Texas                     77014
--------------------------------------------------------------------------------
  (Address of principal executive offices)                       Zip Code

                                (713) 583-5491
--------------------------------------------------------------------------------
             (Registrant's telephone number, including area code)


<PAGE>   2









This Form 8K/A Amendment No. 2 updates the Registrant's report on Form 8-K dated
December 6, 1994, reporting the approval of the merger transaction described in
the Registrant's proxy statement dated November 11, 1994, by the Registrant's
shareholders.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(a)      Financial Statements (attached following the signature page):

         Certain financial information of the Registrant and its subsidiaries as
of the dates and for the periods listed below has been previously reported in
the Registrant's Proxy Statement dated November 11, 1994. Additionally, certain
financial information for AmeriHealth, Inc. has been previously reported in its
Form 10-Q for the nine months ended September 30, 1994. Certain financial
information of the Registrant and its subsidiaries as of the dates and for the
periods listed below has been previously reported in the Registrant's Form 8-K/A
(Amendment No. 1) amending Form 8-K dated December 6, 1994. Accordingly, such
information is not being included in reliance on General Instructions B.3 to
Form 8-K because it has been previously reported.

         AMERIHEALTH, INC.

         Condensed Consolidated Statement of Operations for the eleven months
                  ended November 30, 1994 (Unaudited)(1)
         Condensed Consolidated Statement of Cash Flows for the eleven months
                  ended November 30, 1994 (Unaudited) (1)
         Notes to Condensed Consolidated Financial Statements (Unaudited) (1)

         Condensed Consolidated Statement of Financial Position as of September
                  30, 1994 (Unaudited) (4)
         Condensed Consolidated Statement of Operations for the quarter and nine
                  months ended September 30, 1994 and 1993 (Unaudited) (4)
         Condensed Consolidated Statement of Cash Flows for the nine months
                   ended September 30, 1994 and 1993 (Unaudited) (4)
         Notes to Condensed Consolidated Financial Statements (Unaudited) (4)

         Consolidated Statement of Financial Position as of December 31, 1993
                  and 1992(3)
         Consolidated Statement of Operations for the years ended December 31,
                  1993, 1992 and 1991(3)
         Consolidated Statement of Shareholders' Equity for the years ended
                  December 31, 1993, 1992 and 1991(3)
         Consolidated Statement of Cash Flows for the years ended December 31,
                  1993, 1992 and 1991(3)
         Notes to Consolidated Financial Statements(3)

         CHAMPION HEALTHCARE CORPORATION

         Condensed Consolidated Balance Sheet at September 30, 1994
                  (Unaudited)(2)
         Condensed Consolidated Statement of Operations for the nine months
                  ended September 30, 1994 and 1993(Unaudited) (2)
         Condensed Consolidated Statement of Cash Flows for the nine months
                  ended September 30, 1994 and 1993(Unaudited)(2)
         Notes to Condensed Consolidated Financial Statements(Unaudited)(2)

         Consolidated Balance Sheets at December 31, 1993 and 1992(3)
         Consolidated Statement of Operations for the years ended December 31,
                  1993, 1992 and 1991(3)
         Consolidated Statement of Shareholders' Equity for the years
                  ended December 31, 1993, 1992 and 1991(3)
         Consolidated Statement of Cash Flows for the years ended December 31,
                  1993, 1992 and 1991(3) 
         Notes to Consolidated Financial Statements(3)


<PAGE>   3

         PSYCHIATRIC HEALTHCARE CORPORATION

         Condensed Consolidated Balance Sheet as of September 30, 1994
                  (Unaudited)(2)
         Condensed Consolidated Statement of Operations for the nine months
                  ended September 30, 1994 and 1993(Unaudited) (2)
         Condensed Consolidated Statement of Cash Flows for the nine months
                  ended September 30, 1994 and 1993(Unaudited)(2)
         Notes to Condensed Consolidated Financial Statements(Unaudited)(2)

         Consolidated Balance Sheets as of December 31, 1993, 1992 and 1991(3)
         Consolidated Statement of Operations for the years ended December 31,
                  1993, 1992 and 1991(3)
         Consolidated Statement of Shareholders' Equity for the years ended
                  December 31, 1993, 1992 and 1991(3)
         Consolidated Statement of Cash Flows for the years ended December 31,
                  1993, 1992 and 1991(3)
         Notes to Consolidated Financial Statements(3)

         GULF COAST HOSPITAL(3)

         Balance Sheets as of December 31, 1991 and 1990
         Statement of Operations for the years ended December 31, 1991 and 1990
         Statement of Accumulated Deficit for the years ended December 31, 1991
                  and 1990 
         Statement of Cash Flows for the years ended December 31, 1991 and 1990
         Notes to Financial Statements

         Condensed Balance Sheet as of August 31, 1992(Unaudited)
         Condensed Statement of Operations for the eight months ended August 31,
                  1992(Unaudited) 
         Condensed Statement of Cash Flows for the eight months ended August 31,
                  1992(Unaudited)
         Notes to Condensed Financial Statements(Unaudited)

         MIDLAND PHYSICIANS & SURGEONS HOSPITAL, INC. AND SUBSIDIARY(3)

         Balance Sheet as of April 30, 1993, June 30, 1992 and 1991
         Statement of Operations for the ten months ended April 30, 1993 and the
                  years ended June 30, 1993 and 1991
         Statementof Stockholders' Equity for the ten months ended April 30,
                  1993 and the years ended June 30, 1992 and 1991
         Statementof Cash Flows for the ten months ended April 30, 1993 and the
                  years ended June 30, 1992 and 1991
         Notes to Financial Statements


<PAGE>   4

         ST. ANSGAR HOSPITAL (PREDECESSOR TO HEARTLAND MEDICAL CENTER) (3)

         Consolidated Balance Sheet as of August 31, 1992
         Consolidated Statement of Revenue and Expenses and Changes in Fund
                  Balance (Deficiency in Assets) for the eleven months ended
                  August 31, 1992
         Consolidated Statement of Cash Flows for the eleven months ended August
                  31, 1992
         Notes to Consolidated Financial Statements
                 -
         Consolidated Balance Sheets as of September 30, 1991 and 1990
         Consolidated Statements of Revenue and Expenses and Changes in Fund
                  Balance for the years ended September 30, 1991 and 1990
         Consolidated Statements of Cash Flows for the years ended September 30,
                  1991 and 1990 Notes to Consolidated Financial Statements

         (1)      Included in this Form 8-K/A, Amendment No. 2
         (2)      Previously reported in this Form 8-K/A, Amendment No. 1
         (3)      Previously reported in Proxy Statement dated November 11, 1994
         (4)      Previously reported in AmeriHealth, Inc.'s Form 10-Q for the
                  nine months ended September 30, 1994


<PAGE>   5









(b)      Pro Forma Financial Information:

         Champion Combined Company and Dakota Hospital

                  Pro Forma Combining Income Statement
                  For the Nine Months Ended September 30, 1994

                  Pro Forma Combining Income Statement
                  For the Year Ended December 31, 1993

                  Pro Forma Combining Balance Sheet
                  September 30, 1994

                  Notes to Pro Forma Combining Financial Statements

         Champion Combined Group and AmeriHealth, Inc. (Combined Company)

                  Pro Forma Combining Income Statement
                  For the Nine Months Ended September 30, 1994

                  Pro Forma Combining Income Statement
                  For the Year Ended December 31, 1993

                  Pro Forma Combining Balance Sheet
                  September 30, 1994

                  Notes to Pro Forma Combining Financial Statements

         Champion Combined Group

                  Champion Healthcare Corporation and Psychiatric Healthcare 
                    Corporation
                  Pro Forma Combining Income Statement
                  For the Nine Months Ended September 30, 1994

         Champion Healthcare Corporation, Midland Physicians and Surgeons 
                  Hospital, Inc. and Psychiatric Healthcare Corporation

                  Pro Forma Combining Income Statement
                  For the Year Ended December 31, 1993

         Champion Healthcare Corporation and Psychiatric Healthcare Corporation

                  Pro Forma Combining Balance Sheet, September 30, 1994
                  Notes to Pro Forma Combining Financial Statements


<PAGE>   6












                                  SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by 
the undersigned, thereunto duly authorized.

Dated: August 4, 1995                    Champion Healthcare Corporation
                                         (Registrant)





                                         By: /s/ James G. VanDevender
                                                 -----------------------------
                                                 James G. VanDevender

                                                 Executive Vice President 
                                                 and Chief Financial Officer
                                                 (Principal Financial Officer)


<PAGE>   7




                                AMERIHEALTH, INC.

                   CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                  FOR THE ELEVEN MONTHS ENDED NOVEMBER 30, 1994


<PAGE>   8








                                      INDEX

                                AMERIHEALTH, INC.
<TABLE>
<CAPTION>

                                                                                                            Page
                                                                                                          Number
                                                                                                          ------
<S>                                                                                                        <C>
         FINANCIAL INFORMATION

                  Condensed consolidated statement of operations for the eleven months
                      ended November 30, 1994 (unaudited)                                                    3

                  Condensed consolidated statement of cash flows for the eleven months ended
                      November 30, 1994  (unaudited)                                                         4
                                 

                  Notes to condensed consolidated financial statements (unaudited)                           5
</TABLE>






                                        2


<PAGE>   9



AMERIHEALTH, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>

                                                    Eleven Months
                                                       Ended
                                                  November 30, 1994
                                                  -----------------
<S>                                                   <C>     
Net patient service revenue                           $ 35,811
Other income                                             1,142
                                                      --------

         Net revenue                                    36,953

Operating expenses:
  Salaries and wages                                    16,558
  Other operating and administrative                    16,471
  Provision for doubtful accounts                        4,163
  Interest expense                                       1,666
  Depreciation and amortization                          1,909
                                                      --------

         Total operating expenses                       40,767
                                                      --------
         Operating loss                                 (3,814)

Minority Interest                                           21
                                                      --------
         Loss before income taxes                       (3,793)

    Benefit for income taxes                               948
                                                      --------
         Net loss                                     $ (2,845)
                                                      ========
Net loss                                              $ (2,845)
Series B Preferred Stock dividend requirements              (4)
                                                      --------
         Net loss applicable to common stock          $ (2,849)
                                                      ========
Loss per share:
  Primary                                             $   (.20)
                                                      ========
  Fully Diluted                                       $     --
                                                      ========
</TABLE>

  See notes to condensed consolidated financial statements.

                                      3


<PAGE>   10

AMERIHEALTH, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)
(DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>

                                                   Eleven Months
                                                       Ended
                                                  November 30, 1994
                                                  -----------------
<S>                                                    <C>     
Operating activities:
  Net loss                                             $(2,845)
  Depreciation and amortization                          1,909
  Provision for doubtful accounts                        4,163
  Increase in current assets                              (665)
  Decrease in liabilities                                 (530)
                                                       -------
       Net cash provided by operating activities         2,032
                                                       -------
Investing activities:
  Additions to property and equipment                     (835)
  Other                                                   (201)

       Net cash used in investing activities            (1,036)
                                                       -------

Financing activities:
  Payments on debt and capital lease obligations        (1,233)
                                                       -------
      Net cash used in financing activities             (1,233)
                                                       -------
      Decrease in cash and cash equivalents               (237)

Cash and cash equivalents at beginning of period         3,493
                                                       -------

Cash and cash equivalents at end of period             $ 3,256
                                                       =======
</TABLE>



See notes to condensed consolidated financial statements.

                                        4


<PAGE>   11





        AMERIHEALTH, INC.
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

        NOTE 1 -- BASIS OF PRESENTATION

        The accompanying unaudited condensed consolidated financial statements
        of AmeriHealth, Inc. and its subsidiaries ("AmeriHealth") have been
        prepared in accordance with generally accepted accounting principles for
        interim financial information and in accordance with Rule 3-02 of
        Regulation S-X. Accordingly, these financial statements do not include
        all of the information and disclosures required by generally accepted
        accounting principles for complete financial statements. In the opinion
        of management, all adjustments (consisting of normal recurring accruals)
        considered necessary for a fair presentation of the results for the
        periods presented have been reflected.

        These financial statements should be read in conjunction with the
        audited consolidated financial statements of AmeriHealth for the year
        ended December 31, 1993, included in AmeriHealth's definitive Proxy
        Statement, dated November 11, 1994, and in conjunction with the Annual
        Report of AmeriHealth's successor, Champion Healthcare Corporation
        ("Champion"), included on Form 10-K, as amended, for the year ended
        December 31, 1994.

        AmeriHealth merged with Champion on December 6, 1994. The transaction
        was accounted for as a reverse acquisition with AmeriHealth as the
        surviving entity and Champion as the accounting acquiror. Concurrent
        with the merger, the name of the combined company was changed to
        Champion Healthcare Corporation, and the combined company adopted
        Champion's certificate of incorporation provisions (See "Note 4 --
        Subsequent Event").

        Net patient service revenues are presented based on established billing
        rates less allowances and discounts for patients covered by Medicare,
        Medicaid and other contractual programs. Payments received under these
        programs are generally less than the established billing rates of
        AmeriHealth's hospitals, and the differences are recorded as contractual
        allowances or discounts. Such allowances have been deducted from
        accounts receivable pending final audit and settlement. Provisions for
        contractual allowances and discounts for the eleven months ended
        November 30, 1994 were $25,578,000.

        In the ordinary course of business, AmeriHealth rendered services
        (charity care) in its facilities to patients who are financially unable
        to pay for hospital care. The value of these services was not material
        to AmeriHealth's Condensed Consolidated Statement of Operations.

        NOTE 2 -- SIGNIFICANT ADJUSTMENTS

        The results for the eleven months ended November 30, 1994, included
        approximately $2,603,000 in merger related expenses, which consisted of
        approximately $688,000 in severance costs for certain officers and key
        employees, $663,000 in various professional fees, and an additional
        $1,252,000 in provision for doubtful accounts (See "Note 4 -- Subsequent
        Event").

        NOTE 3 -- LOSS PER SHARE

        Primary loss per share is computed by dividing loss attributable to
        common shareholders (net loss less preferred stock dividend
        requirements) by the weighted average number of common shares
        outstanding during the eleven months ended November 30, 1994. Common
        equivalent shares (consisting of officer and key employee stock options)
        were antidilutive and therefore excluded from the calculation of primary
        loss per share. Fully diluted per share information was not presented
        for the eleven months ended November 30, 1994 due to the antidilutive
        effect of such calculation.

        For the eleven months ended November 30, 1994, 97,000 shares of Series B
        Preferred Stock were converted into 4,850,000 shares of AmeriHealth's
        Common Stock. If these conversions had occurred on January 1, 1994,
        primary and fully diluted loss per share would have been $0.16 for the
        eleven months ended November 30, 1994.

                                        5
<PAGE>   12





        AMERIHEALTH, INC.
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) -- 
        CONTINUED

        NOTE 3 -- LOSS PER SHARE -- CONTINUED

        The weighted average number of shares used in computing primary income
        per share for the eleven months ended November 30, 1994 was 14,448,505.

        NOTE  4 -- SUBSEQUENT EVENT

        Merger

        On December 6, 1994, AmeriHealth merged with Champion Healthcare
        Corporation, a Texas corporation, with AmeriHealth being the surviving
        corporation resulting from the merger (the "Combined Company"). The
        merger was accounted for as a recapitalization of Champion with Champion
        as the acquiror (a reverse acquisition). Concurrent with the merger, the
        name of the Combined Company was changed to Champion Healthcare
        Corporation, and the Combined Company adopted Champion's certificate of
        incorporation provisions.

        Pursuant to the merger, the Combined Company: (a) paid a cash
        distribution of $0.085 cents per share to all common stockholders of
        AmeriHealth, (b) issued one share of its Combined Company common stock
        for each 5.70358 shares of the approximately 17.2 million outstanding
        shares of AmeriHealth's Common Stock (plus cash in lieu for fractional
        shares); (c) one share of Combined Company common stock for each of the
        approximately 1.2 million then outstanding shares of Champion common
        stock; and (d) one share of newly authorized Combined Company preferred
        stock for each of the then outstanding shares of Champion's preferred
        stock. The terms of the new voting shares of Combined Company preferred
        stock are identical to those of Champion's preferred stock outstanding
        prior to the merger. In addition, holders of the outstanding shares of
        AmeriHealth's $2.125 Increasing Rate Cumulative Convertible Preferred
        Stock were canceled in exchange for cash equal to the redemption price
        of such shares plus all unpaid dividends, which totaled approximately
        $47,000. The net purchase price, including the assumption of
        approximately $17,700,000 in debt, was approximately $38,300,000. The
        transaction was subject to the approval by stockholders of each company,
        which was obtained on December 6, 1994.

       
                                      6

<PAGE>   13
                   PRO FORMA COMBINED SELECTED FINANCIAL DATA

                  Champion Combined Company and Dakota Hospital
                    Pro Forma Combining Financial Statements

         The following Pro Forma Combining Balance Sheet as of September 30,
1994 and Pro Forma Combining Income Statements for the nine months ended
September 30, 1994 and for the year ended December 31, 1993, illustrate the
effect of the formation of the partnership (the "Partnership") between the
wholly owned subsidiary of Champion Healthcare Corporation, a Delaware
Corporation, (the "Company") that owned Heartland Medical Center ("HMC"), a 139
bed general acute care hospital in Fargo, North Dakota and Dakota Hospital
("Dakota"), a North Dakota not-for-profit corporation that owned Dakota
Hospital, a 199 bed general acute care hospital in Fargo, North Dakota. The
partnership is operated as Dakota Heartland Health System ("DHHS"). The Pro
Forma Combining Balance Sheet assumes that the Partnership was formed on
September 30, 1994 and the Pro Forma Combining Income Statements assume the
Partnership was formed on January 1, 1993.

         In connection with the formation of the Partnership, the Company and
Dakota contributed their respective hospitals both debt and lien free (except
capitalized leases), and the Company contributed an additional $20,000,000 in
cash, each in exchange for 50% ownership in the Partnership. In addition, each
partner contributed $2,000,000 in cash to the working capital of the
Partnership. A $20,000,000 special distribution was made to Dakota after
capitalization of the Partnership in accordance with the terms of the
Partnership agreement. The ownership interest acquired by each partner was based
on the value of the assets contributed to the Partnership.

            Also on December 21, 1994, the Company entered into an operating
agreement with the Partnership and Dakota to manage the combined operations of
the two hospitals. Under the terms of the Partnership agreement, the Company is
obligated to advance funds to the Partnership to cover any and all operating
deficits of the Partnership. The Company will receive 55% of the net income and
distributable cash flow ("DCF") of the Partnership until such time as it has
recovered on a cumulative basis an additional $10,000,000 of DCF in the form of
an "excess" distribution. The Company accounts for its investment in DHHS under
the equity method. DHHS began operations on December 31, 1994.

            The Partnership is administered by a Governing Board comprised of
six members appointed by Dakota, three members appointed by the Company and
three members appointed by mutual consent of the Dakota members and the Company
members. Certain Governing Board actions require the majority approval of each
of the Company members and Dakota members. Because the partners through the
Partnership agreement have delegated management of the Partnership to the
Company through the operating agreement, the authority of the Governing Board is
limited.

            From the 19th month after the commencement of the Partnership,
Dakota has the right to require the Company to purchase its Partnership interest
free of debt or liens for a cash purchase price equal to 5.5 times earnings
before depreciation, interest, income taxes and amortization less Dakota's
pro-rata share of the Partnership's long-term debt. From the 37th month after
the commencement of the Partnership, the purchase price for Dakota's Partnership
interest shall not be less than $50,000,000. After receipt of written notice of
Dakota's intent to sell its Partnership interest, the Company would have 12
months to complete the purchase. Should the Company not complete the purchase
during this period, Dakota would have the right to, among others, (i) terminate
the operating agreement and engage an outside party to manage the hospital, (ii)
replace the Company's designees to the Governing Board and (iii) enter into a
fair market value transaction to sell substantially all of the Partnership's
assets. The Company would likely finance the purchase through bank or other
borrowings.

         The Pro Forma Combining Financial Statements should be read in
conjunction with the Company's consolidated financial statements for the year
ended December 31, 1994, included in the Company's Annual Report on Form 10K, as
amended, the Company's condensed consolidated financial statements for the
quarter ended March 31, 1995 (unaudited), included in the Company's Quarterly
Report on Form 10-Q, as amended, and Dakota's 

                                       1
<PAGE>   14

financial statements for the years ended September 31, 1994 and 1993 and for the
quarter ended December 31, 1994 (unaudited), included in the Company's report on
Form 8-K/A, Amendment No. 2, dated December 21, 1994.

         The Pro Forma Combining Financial Statements are presented for
comparative purposes only and are not intended to be indicative of actual
results had the transactions occurred as of the dates indicated above, nor do
they purport to indicate results which may be attained in the future.

                                       2
<PAGE>   15


                  CHAMPION COMBINED COMPANY AND DAKOTA HOSPITAL
                      PRO FORMA COMBINING INCOME STATEMENT
                  FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1994
                       (Thousands, except per share data)

<TABLE>
<CAPTION>

                                                       Champion
                                                       Combined     Pro Forma                   Pro Forma
                                                       Company     Adjustments       Reference   Combined
                                                       -------     -----------       ---------   --------
<S>                                                   <C>           <C>                  <C>    <C>      
Total revenue                                         $ 121,803     $    (558)           (1)    $  91,255
                                                                      (29,990)           (2)

Expenses:
    Salaries and benefits                                47,961       (10,434)           (2)       37,527
    Supplies                                             13,517        (3,787)           (2)        9,730
    Other operating expenses                             33,902        (8,176)           (2)       25,726
    Provision for bad debts                              10,096          (689)           (2)        9,407
    Interest                                              7,421           (28)           (2)        7,393
    Depreciation and amortization                         5,959          (489)           (2)        5,470
    Equity in earnings of DHHS                             --          (4,558)           (3)       (4,558)
                                                      ---------     ---------                   --------- 
        Total expenses                                  118,856       (28,161)                     90,695
                                                      ---------     ---------                   --------- 
        Operating income                                  2,947        (2,387)                        560

Minority interest                                          (164)                                     (164)
                                                      ---------     ---------                   --------- 
        Income before taxes                               2,783        (2,387)                        396

(Provision) benefit for income taxes                        (73)          945            (5)          872
                                                      ---------     ---------                   --------- 
        Income from continuing operations                 2,710        (1,442)                      1,268


Adjustments to arrive at income applicable to
    common stock                                         (3,795)                                   (3,795)
                                                      ---------     ---------                   --------- 
       Loss from continuing operations
           applicable to common stock                 $  (1,085)    $  (1,442)                  $  (2,527)
                                                      =========     =========                   ========= 
       Loss from continuing operations per
           common and common equivalent share         $   (0.25)                                $   (0.59)
                                                      =========                                 ========= 
Shares used in loss from continuing operations per
  common and common equivalent share
  computation (in thousands):                             4,260                                     4,260
                                                      =========                                 ========= 
</TABLE>

See notes to pro forma combining financial statements (Champion Combined Company
and Dakota Hospital).

                                       3
<PAGE>   16


                  CHAMPION COMBINED COMPANY AND DAKOTA HOSPITAL
                      PRO FORMA COMBINING INCOME STATEMENT
                      FOR THE YEAR ENDED DECEMBER 31, 1993
                       (Thousands, except per share data)

<TABLE>
<CAPTION>

                                                  Champion
                                                  Combined      Pro Forma                      Pro Forma
                                                  Company      Adjustments        Reference    Combined
                                                  -------      -----------        ---------    --------
<S>                                               <C>           <C>               <C>          <C>      
Total revenue                                     $ 160,796     $ (39,182)           (2)       $ 121,614

Expenses:
    Salaries and benefits                            67,675       (14,944)           (2)          52,731
    Supplies                                         25,252        (5,411)           (2)          19,841
    Other operating expenses                         39,144        (9,072)           (2)          30,072
    Provision for bad debts                          11,477        (1,541)           (2)           9,936
    Interest                                          7,221         2,143           (2)(4)         9,364
    Depreciation and amortization                     8,568          (577)           (2)           7,991
    Equity in earnings of DHHS                         --          (3,908)           (3)          (3,908)
    Asset write-off                                  15,456          --                           15,456
                                                  ---------     ---------                      --------- 
        Total expenses                              174,793       (33,310)                       141,483
                                                  ---------     ---------                      --------- 
        Operating loss                              (13,997)       (5,872)                       (19,869)
Minority interest                                      (234)                                        (234)
                                                  ---------     ---------                      --------- 
       Loss before taxes                            (14,231)       (5,872)                       (20,103)

(Provision) benefit for income taxes                 (1,289)        2,009            (5)             720
                                                  ---------     ---------                      --------- 
        Loss from continuing operations             (15,520)       (3,863)                       (19,383)

Adjustments to arrive at loss applicable to
    common stock                                     (2,036)                                      (2,036)
                                                  ---------     ---------                      --------- 

       Loss from continuing operations
           applicable to common stock             $ (17,556)    $  (3,863)                     $ (21,419)
                                                  =========     =========                      ========= 

       Loss from continuing operations per
           common and common equivalent share     $   (4.24)                                   $   (5.18)
                                                  =========                                    ========= 
Shares used in loss from continuing operations
    per common and common equivalent share
    computation (in thousands):                       4,136                                        4,136
                                                  =========                                    ========= 
</TABLE>

See notes to pro forma combining financial statements (Champion Combined Company
and Dakota Hospital).


                                       4

<PAGE>   17
                 CHAMPION COMBINED COMPANY AND DAKOTA HOSPITAL
                       PRO FORMA COMBINING BALANCE SHEET
                               SEPTEMBER 30, 1994
                             (Dollars in thousands)


<TABLE>
<CAPTION>
                                           Champion
                                           Combined                  Pro Forma                          Pro Forma
                                           Company                  Adjustments     Reference           Combined
                                           -------                  -----------     ---------           --------
<S>                                        <C>                       <C>                <C>             <C>
ASSETS:

CURRENT ASSETS:
  Cash and cash equivalents                $ 47,061                  $(22,250)          (6)             $ 24,811
  Restricted cash                               201                                                          201
  Accounts receivable, net                   28,173                    (7,208)          (7)               20,965
  Supplies inventory                          2,400                      (452)          (7)                1,948
  Other                                       7,602                      (834)          (7)                6,768
                                           --------                  --------                           --------
    TOTAL CURRENT ASSETS                     85,437                   (30,744)                            54,693

PROPERTY AND EQUIPMENT, net                  85,953                    (9,564)                            76,389

OTHER ASSETS:
  Trusteed funds                              1,247                                                        1,247
  Deferred charges                            4,051                                                        4,051
  Goodwill                                    5,900                                                        5,900
  Investment in DHHS                             --                    37,400           (7)               37,400
  Other                                       5,863                      (300)          (7)                5,563
                                           --------                  --------                           --------

    TOTAL ASSETS                           $188,451                  $ (3,208)                          $185,243
                                           ========                  ========                           ========
LIABILITIES AND
  SHAREHOLDERS' EQUITY:

CURRENT LIABILITIES:
  Current portion of debt and capital
      lease obligations                    $  4,507                  $   (136)          (7)             $  4,371
  Accounts payable                            8,959                    (1,361)          (7)                7,598
  Other current liabilities                   8,301                    (1,586)          (7)                6,715
                                           --------                  --------                           --------

    TOTAL CURRENT LIABILITIES                21,767                    (3,083)                            18,684

DEBT AND CAPITAL LEASE
  OBLIGATIONS                                91,290                      (125)          (7)               91,165

OTHER LONG-TERM LIABILITIES                  10,174                                                       10,174

REDEEMABLE PREFERRED STOCK                   65,177                                                       65,177

SHAREHOLDERS' EQUITY:
  Common Stock                                   45                                                           45
  Additional paid-in capital                 16,563                                                       16,563
  Retained (deficit)/fund balance           (16,565)                                                     (16,565)
                                           --------                  --------                           --------

    TOTAL SHAREHOLDERS'
      EQUITY                                     43                                                           43
                                           --------                  --------                           --------

    TOTAL LIABILITIES AND
      SHAREHOLDERS' EQUITY                 $188,451                  $ (3,208)                          $185,243
                                           ========                  ========                           ========
</TABLE>


See notes to pro forma combining financial statements (Champion Combined Company
and Dakota Hospital).



                                       5

<PAGE>   18

                CHAMPION COMBINED COMPANY AND DAKOTA HOSPITAL
              NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

         The following is a summary of the pro forma adjustments by line item.

    Reference to Notes to 
     Pro Forma Financial 
         Statements           Explanations
    ---------------------     --------------------------------------------------

            (1)               To reflect a decrease in interest earnings for the
                              pro forma decrease in cash. This adjustment
                              assumes the Company's $20,000,000 capital
                              contribution to the Partnership and its $2,000,000
                              contribution to Partnership working capital were
                              made from available cash at January 1, 1994.
                              Interest earnings are computed at 3.38%, the
                              Company's average investment rate for the period.
                              Revenue for the period ended December 31, 1993 did
                              not include interest revenue; therefore, a pro
                              forma reduction in interest earnings is not needed
                              for such period.

            (2)               To remove the historical operating results of HMC
                              for the nine months ended September 30, 1994, and
                              the year ended December 31, 1993.

            (3)               The Company is entitled to 55% of the first $100
                              million in net income of the Partnership, after
                              which net income will be allocated on a 50/50
                              basis. The following represents the income
                              allocation.

<TABLE>
<CAPTION>
                                                                       September 30,    December 31,
                                                                           1994             1993
                                                                           ----             ----
                                <S>                                       <C>             <C>
                                Dakota operating income (loss)            $  214          $  (855)

                                Pro forma adjustments to Dakota
                                   operating income (loss)(a)              1,686              382
                                                                          ------          -------
                                Dakota pro forma operating income
                                   (loss) attributable to the
                                   Partnership                             1,900             (473)

                                Heartland Medical Center operating
                                   income attributable to the
                                   Partnership                             6,387            7,580
                                                                          ------          -------
                                Pro forma Partnership operating income     8,287            7,107

                                Company's equity participation in the
                                   pro forma earnings of DHHS                 55%              55%
                                                                          ------          -------
                                Company's equity in the pro forma
                                   earnings of DHHS                       $4,558          $ 3,908
                                                                          ======          =======
</TABLE>
                                (a) To remove interest expense associated with
                                debt not contributed to the Partnership and
                                gains on investments not contributed to the
                                Partnership. The pro forma adjustment to
                                interest expense was approximately $1,708,000
                                and $1,591,000, respectively, for the nine
                                months ended September 30, 1994 and the year
                                ended December 31, 1993. The pro forma
                                adjustment to gains on investment was
                                approximately $22,000 and $1,209,000,
                                respectively, for the comparable periods.

            (4)               To reflect a pro forma increase in interest
                              expense of approximately $2,000,000. The pro forma
                              results for the year ended December 31, 1993,
                              assume the funds required to fund the Company's
                              $20,000,000 capital contribution to the
                              Partnership and its $2,000,000 contribution to the
                              Partnership's working capital were obtained at
                              10%, the Company's borrowing rate under its prior
                              Senior Subordinated Notes at January 1, 1993.

            (5)               To reflect the pro forma benefit for income taxes
                              due to the inclusion of the acquired operations
                              and the pro forma allocation of HMC operating
                              income to the Dakota partner.

                                       6
<PAGE>   19
                  CHAMPION COMBINED COMPANY AND DAKOTA HOSPITAL
                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

         The following is a summary of the pro forma adjustments by line item.


    Reference to Notes to 
     Pro Forma Financial 
         Statements           Explanations
    ---------------------     --------------------------------------------------

            (6)               To record the Company's $20,000,000 capital
                              contribution to the Partnership and its $2,000,000
                              contribution to the Partnership's working capital.
                              The Company also incurred approximately $250,000
                              in costs associated with the Partnership's
                              formation.

            (7)               To remove HMC assets and liabilities contributed
                              to DHHS.


                                       7
<PAGE>   20
                   PRO FORMA COMBINED SELECTED FINANCIAL DATA

                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                               (COMBINED COMPANY)
                    PRO FORMA COMBINING FINANCIAL STATEMENTS

         The following Pro Forma Combining Balance Sheet as of September 30,
1994 and Pro Forma Combining Income Statements for the nine months ended
September 30, 1994 and for the year ended December 31, 1993, illustrate the
effect of the merger (the "Merger") of Champion Healthcare Corporation, a Texas
Corporation, ("Old Champion") with AmeriHealth, Inc. on December 6, 1994. The
Pro Forma Combining Balance Sheet assumes that the Merger occurred on September
30, 1994, and the Pro Forma Combining Income Statements assume that the Merger
occurred on January 1, 1993.

         In connection with the consummation of the Merger, holders of the
AmeriHealth ("AHH") Common Stock received one share of Combined Company Common
Stock for each 5.70358 shares of AHH Common Stock and cash in lieu of fractional
shares. Holders of AHH Series B Preferred Stock not converted into AHH Common
Stock received cash equal to the redemption price of such shares plus accrued
dividends. Such shares were then canceled in connection with the Merger. Also,
in connection with the Merger, the Combined Company issued shares of the
Combined Company Common Stock and issued five new series of preferred stock of
the Combined Company to the Old Champion shareholders in exchange for their Old
Champion Common and Preferred Stock.

         AHH declared and paid dividends on the AHH Common Stock and AHH Series
B Preferred Stock as follows: (a) to holders of record of the AHH Common Stock
at the close of business on the business day immediately preceding the date of
consummation of the Merger in the amount of 8 1/2 cents ($0.085) per share; and
(b) to holders of record of the AHH Series B Preferred Stock immediately prior
to consummation of the Merger in the amount of $21.72 per share. The foregoing
dividend payments were conditioned upon consummation of the Merger.

         The Merger was accounted for as a purchase transaction. For accounting
purposes, the Company was deemed to be the surviving entity of the Merger with
the name of the Combined Company changed to Champion Healthcare Corporation, a
Delaware Corporation.

         These Pro Forma Combining Financial Statements should be read in
conjunction with the Company's consolidated financial statements for the year
ended December 31, 1994, included in the Company's Annual Report on Form 10K, as
amended, the Company's condensed consolidated financial statements for the
quarter ended March 31, 1995 (unaudited), included in the Company's Quarterly
Report on Form 10-Q, as amended, the historical financial statements of
AmeriHealth, Inc. included in the definitive Proxy Statement of AmeriHealth,
Inc., dated November 11, 1994, the AmeriHealth, Inc. Form 10-Q for the nine
months ended September 30, 1994 (unaudited), and elsewhere herein.

         The Pro Forma Combining Financial Statements are presented for
comparative purposes only and are not intended to be indicative of actual
results had the transactions occurred as of the dates indicated above, nor do
they purport to indicate results which may be attained in the future.

                                       8

<PAGE>   21
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                      PRO FORMA COMBINING INCOME STATEMENT
                  FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1994
                       (THOUSANDS, EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>
                                                      Champion
                                                      Combined                     Pro Forma                      Pro Forma
                                                        Group       AmeriHealth   Adjustments       Reference     Combined
                                                        ----        -----------   -----------       ---------     --------

<S>                                                   <C>            <C>            <C>                 <C>       <C>
Total revenue                                         $ 89,739       $ 32,270       $   (206)           (1)       $121,803

Expenses:
    Salaries and benefits                               35,065         12,896                                       47,961
    Supplies                                             9,163          4,354                                       13,517
    Other operating expenses                            25,130          8,772                                       33,902
    Provision for bad debts                              7,646          2,450                                       10,096
    Interest                                             6,600          1,335           (514)           (2)          7,421
    Depreciation and amortization                        3,597          1,543            819            (3)          5,959
                                                      --------       --------       --------                      --------

        Total expenses                                  87,201         31,350            305                       118,856
                                                      --------       --------       --------                      --------
        Operating income                                 2,538            920           (511)                        2,947
Minority interest                                                        (164)                                        (164)
                                                      --------       --------       --------                      --------
        Income before taxes                              2,538            756           (511)                        2,783

Benefit (provision) for income taxes                        32           (274)           169            (4)            (73)
                                                      --------       --------       --------                      --------
        Income from continuing operations                2,570            482           (342)                        2,710


Adjustments to arrive at (loss) income from
    continuing operations applicable to common
    stock                                               (3,795)           (82)            82            (6)       (3,795)
                                                      --------       --------       --------                      --------

       Net (loss) income from continuing
           operations applicable to common stock      $ (1,225)      $    400       $   (260)                     $ (1,085)
                                                      ========       ========       ========                      ========


       (Loss) income from continuing
           operations per common and common
           equivalent share                           $  (1.01)      $   0.03                                     $   (0.25)
                                                      ========       ========                                      ======= 

Shares used in (loss) income from continuing
    operations per common and common equivalent
    share computation (in thousands):                    1,209         14,098        (11,047)           (7)        4,260
                                                      ========       ========       ========                       ======= 

</TABLE>


See notes to pro forma combining financial statements (Champion Combined Group
and AmeriHealth, Inc.).



                                       9

<PAGE>   22
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                      PRO FORMA COMBINING INCOME STATEMENT
                      FOR THE YEAR ENDED DECEMBER 31, 1993
                       (Thousands, except per share data)

<TABLE>
<CAPTION>
                                                 Champion
                                                 Combined                  Pro Forma                Pro Forma
                                                   Group     AmeriHealth  Adjustments   Reference    Combined
                                                 ---------   -----------  -----------   ---------   ---------
<S>                                              <C>          <C>          <C>          <C>         <C>
Total revenues                                   $ 116,499    $  44,297                             $ 160,796

Expenses:
    Salaries and benefits                           49,512       18,163                                67,675
    Supplies                                        18,887        6,365                                25,252
    Other operating expenses                        26,628       12,516                                39,144
    Provision for bad debts                          8,596        2,881                                11,477
    Interest                                         5,315        1,707    $     199       (2)          7,221
    Depreciation and amortization                    5,276        2,200        1,092       (3)          8,568
    Asset write-off                                 15,456           --                                15,456
                                                 ---------    ---------    ---------                ---------

        Total expenses                             129,670       43,832        1,291                  174,793
                                                 ---------    ---------    ---------                ---------

        Operating (loss) income                    (13,171)         465       (1,291)                 (13,997)
Minority interest                                       --         (234)                                 (234)
                                                 ---------    ---------    ---------                ---------
       (Loss) income before taxes                  (13,171)         231       (1,291)                 (14,231)

Provision for income taxes                             (30)      (1,327)          68     (4)(5)        (1,289)
                                                 ---------    ---------    ---------                ---------
        Loss from continuing operations            (13,201)      (1,096)      (1,223)                 (15,520)

Adjustments to arrive at loss from continuing
    operations applicable to common stock           (2,036)        (353)         353       (6)         (2,036)
                                                 ---------    ---------    ---------                ---------

       Loss from continuing operations
           applicable to common stock            $ (15,237)   $  (1,449)   $    (870)               $ (17,556)
                                                 =========    =========    =========                =========

       Loss from continuing operations per
           common and common equivalent share    $  (13.58)   $   (0.11)                            $   (4.24)
                                                 =========    =========                             =========

Shares used in loss from continuing operations
    per common and common equivalent share
    computation (in thousands):                      1,122       13,188      (10,174)      (7)          4,136
                                                 =========    =========    =========                =========
</TABLE>


See notes to pro forma combining financial statements (Champion Combined Group
and AmeriHealth, Inc.).

                                       10
<PAGE>   23
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                        PRO FORMA COMBINING BALANCE SHEET
                               SEPTEMBER 30, 1994
                             (Dollars in thousands)


<TABLE>
<CAPTION>
                                             Champion
                                             Combined                   Pro Forma                 Pro Forma
                                               Group    AmeriHealth    Adjustments   Reference     Combined
                                             --------   -----------    -----------   ---------    ---------
<S>                                          <C>          <C>           <C>           <C>         <C>
   ASSETS:

   CURRENT ASSETS:
       Cash and cash equivalents             $ 58,218     $ 1,981       $(11,629)       (8)       $ 47,061
                                                                          (1,509)       (9)
       Restricted cash                             --         649           (448)       (8)            201
       Accounts receivable, net                22,117       6,056                                   28,173
       Supplies inventory                       1,496         904                                    2,400
       Other                                    3,314       2,617          1,671        (11)         7,602
                                             --------     -------       --------                  --------

         TOTAL CURRENT ASSETS                  85,145      12,207        (11,915)                   85,437

   PROPERTY AND EQUIPMENT, net                 48,601      18,796         18,556        (11)        85,953

   OTHER ASSETS:
     Trusteed funds                                --       1,247                                    1,247
     Deferred charges                           4,051          --                                    4,051
     Goodwill                                   5,900          --                                    5,900
     Other                                      5,067         796                                    5,863
                                             --------     -------       --------                  --------

         TOTAL ASSETS                        $148,764     $33,046       $  6,641                  $188,451
                                             ========     =======       ========                  ========

   LIABILITIES AND
     SHAREHOLDERS' EQUITY:

   CURRENT LIABILITIES:
       Current portion of debt and
           capital lease obligations         $  3,402     $ 9,621       $(8,516)        (8)       $  4,507
       Accounts payable                         6,802       2,157                                    8,959
       Other current liabilities                5,807       2,494                                    8,301
                                             --------     -------       --------                  --------

         TOTAL CURRENT LIABILITIES             16,011      14,272        (8,516)                    21,767

   DEBT AND CAPITAL LEASE
     OBLIGATIONS                               80,505      10,785                                   91,290

   OTHER LONG-TERM LIABILITIES                  3,485       1,284          5,405        (11)        10,174

   REDEEMABLE PREFERRED STOCK                  65,177                                               65,177

   SHAREHOLDERS' EQUITY:
       Series B Preferred Stock                    --         812           (812)     (10)(11)          --
       Common Stock                               151         167           (273)       (11)            45
       Additional paid-in capital                  --       8,728          9,344        (11)        16,563
                                                                          (1,509)       (9)

       Retained deficit                       (16,565)     (3,002)         3,002        (11)       (16,565)
                                             --------     -------       --------                  --------

         TOTAL SHAREHOLDERS'
           EQUITY                             (16,414)      6,705          9,752                        43
                                             --------     -------       --------                  --------

         TOTAL LIABILITIES AND
           SHAREHOLDERS' EQUITY              $148,764     $33,046       $  6,641                  $188,451
                                             ========     =======       ========                  ========
</TABLE>


See notes to pro forma combining financial statements (Champion Combined Group
and AmeriHealth, Inc.).

                                       11
<PAGE>   24
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

         The following is a summary of the pro forma adjustments by line item.

 Reference to Notes to Pro
      Forma Financial
        Statements              Explanations
 -------------------------      -----------------------------------------------
            (1)                 To reflect a decrease in interest earnings for
                                the pro forma decrease in cash. This adjustment
                                assumes the $8,516,000 loan held by the
                                Resolution Trust Corporation (the "RTC Loan")
                                was retired from available cash at January 1,
                                1994, net of a discount of approximately
                                $384,000 obtained by the Company concurrent with
                                the Merger. Interest earnings are computed at
                                3.38%, the Company's average investment rate for
                                the period. Revenue for the period ended
                                December 31, 1993 did not include interest
                                revenue; therefore, a pro forma reduction in
                                interest earnings is not needed for such period.

            (2)                 Concurrent with the Merger, the Company retired
                                the RTC Loan from available funds. The Pro Forma
                                Combining Income Statement for the nine months
                                ended September 30, 1994 assumes the Company
                                retired the RTC Loan ($8,516,000 principle
                                amount net of a discount of approximately
                                $384,000) from funds that became available as a
                                result of the Company's December 31, 1993
                                issuance of Series D Preferred Stock and related
                                11% Senior Subordinated Notes.  The pro forma
                                results for the year ended December 31, 1993
                                assume the funds to retire the RTC Loan were
                                obtained at 10%, the Company's borrowing rate
                                under its prior Senior Subordinated Notes at
                                January 1, 1993.

            (3)                 To adjust depreciation expense based upon the
                                step up in basis for the depreciable assets of
                                AHH. The acquired assets are estimated to have
                                an average remaining useful life of
                                approximately 17 years based upon management's
                                assumption that a hospital's depreciable assets
                                consist of approximately 50% buildings with a 30
                                year life and 50% equipment with a five year
                                life.

            (4)                 To reflect the pro forma provision for income
                                taxes due to the inclusion of the acquired
                                operations. For the purposes of the pro forma
                                provision for income taxes, loss carryovers of
                                the Company can be utilized to reduce the
                                provision for income taxes.

            (5)                 AHH's tax provision includes a valuation
                                allowance of approximately $1,234,000 recognized
                                by AHH in 1993 to offset tax assets related to
                                operating loss and tax credit carryforwards, net
                                of reversing deferred tax credits. The valuation
                                allowance was recognized as a result of the
                                RTC's decision not to extend the maturity of
                                AHH's debt. This change in circumstance raised
                                substantial doubt about AHH's ability to realize
                                the deferred tax assets recorded as a result of
                                the AHH's adoption of Statement of Financial
                                Accounting Standards No. 109, "Accounting for
                                Income Taxes."

            (6)                 To reverse the dividend requirement on the AHH's
                                Series B Preferred Stock. For pro forma
                                purposes, 28,100 AHH Series B shares are assumed
                                to be converted into Combined Company Common
                                Stock in connection with the consummation of the
                                Merger with the remaining 1,000 shares of AHH
                                Series B redeemed at a redemption price of
                                $25.50 per share plus accrued dividends of
                                $21.72 per share.

                                       12
<PAGE>   25
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

 Reference to Notes to Pro
     Forma Financial
        Statements              Explanations
 -------------------------      -----------------------------------------------
            (7)                 To adjust common and common equivalent shares
                                used to calculate income (loss) from continuing
                                operations per share. The pro forma adjustment
                                reflects the following events:

                                (a)   The exchange of each 5.70358 shares of the
                                      AHH common and common equivalent shares
                                      into one share of the Combined Company
                                      Common Stock.  At September 30, 1994,
                                      AHH's common and common equivalent shares
                                      would have decreased from 14,098,000
                                      shares to 2,472,000 common and common
                                      equivalent shares of the Combined Company
                                      Common Stock, and at December 31, 1993,
                                      AHH's common and common equivalent shares
                                      would have decreased from 13,188,000
                                      shares to 2,312,000 common and common
                                      equivalent shares of the Combined Company
                                      Common Stock.

                                (b)   The Company purchased 880,000 shares of
                                      the AHH's Common Stock in a private
                                      transaction. In connection with the
                                      Merger, these shares were retired,
                                      resulting in a reduction of 154,000
                                      shares of Combined Company Common Stock
                                      that would have otherwise been issued.

                                The common shareholders of the Old Champion
                                received one share of the Combined Company
                                Common Stock for each share of Old Champion
                                Common Stock outstanding prior to the merger.
                                The preferred shareholders of the Old Champion
                                received one share of Combined Company Preferred
                                Stock for each share of Old Champion Preferred
                                Stock outstanding prior to the merger.
                                Therefore, the Company's common equivalent
                                shares at September 30, 1994 and December 31,
                                1993 are not adjusted as a result of the Merger.

                                Additionally, AHH Series B Preferred Stock
                                outstanding of 29,100 and 98,000 shares
                                convertible into 1,455,000 and 4,900,000 common
                                shares at September 30, 1994 and December 31,
                                1993, respectively, were not used in the
                                historical equivalent share computation due to
                                the anti-dilutive effect of such inclusion. The
                                Pro Forma Combining Income Statement reflects
                                the exchange of all but 1,000 shares of AHH
                                Series B Preferred Stock for AHH Common Stock
                                before the Merger was consummated. Therefore,
                                based on the outstanding shares listed above,
                                AHH Series B Preferred Stock will exchange into
                                246,000 shares and 850,000 shares of Combined
                                Company Common Stock at September 30, 1994 and
                                December 31, 1993, respectively.

                                The following table summarizes the adjustments
                                to shares used in the calculation of income
                                (loss) from continuing operations per common and
                                common equivalent share:
<TABLE>
<CAPTION>
                                                                                   September 30,     December 31,
                                                                                       1994              1993
                                                                                   -------------     ------------
                                 <S>                                                 <C>               <C>
                                 Adjustment to AHH's common and common
                                   equivalent shares for the exchange
                                   ratio (a)                                           11,626            10,876

                                 AHH common shares canceled (b)                          (726)             (726)

                                 Dilutive effect of shares of AHH Common Stock
                                     issued in exchange for shares of AHH Series
                                     B Preferred Stock during the period and AHH
                                     Series B Preferred Shares canceled in
                                     connection with the Merger.                          147                24
                                                                                     --------          --------
                                                                                       11,047            10,174
                                                                                     ========          ========
</TABLE>
                                       13
<PAGE>   26
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

 Reference to Notes to Pro
     Forma Financial
        Statements              Explanations
 -------------------------      -----------------------------------------------
            (8)                 To record the following cash payments in
                                connection with the merger:
<TABLE>
                                <S>                                                             <C>
                                Payment for stock purchase                                      $   660
                                Retirement of RTC debt, net of  $384 discount
                                 (see Note 11)                                                    8,132
                                Merger expenses                                                   3,285
                                                                                                -------
                                                                                                $12,077
                                                                                                =======
</TABLE>
            (9)                 To record the pro forma cash dividend paid per
                                AHH Common and Preferred share at the
                                consummation of the Merger based on the
                                following shares:
<TABLE>
<CAPTION>
                                                                                      Dividend
                                                                           Shares      Amount
                                                                           ------     --------
                                <S>                                        <C>         <C>
                                AHH Common shares outstanding on
                                  record date                              16,669      $1,417
                                AHH Preferred shares converted into
                                  Common shares (28,100 x 50)               1,405         120

                                AHH Preferred shares redeemed plus
                                  accrued dividends                            --          47
                                Less Champion owned shares                   (880)        (75)
                                                                           ------      ------                            
                                                                           17,194      $1,509
                                                                           ======      ======
</TABLE>
           (10)                 To record the conversion of 28,100 shares of AHH
                                Series B Preferred Stock into 1,405,000 shares
                                of AHH Common Stock subsequent to September 30,
                                1994. Additionally, the pro forma reflects the
                                subsequent redemption of the remaining 1,000
                                shares of AHH Series B Preferred Stock at a
                                redemption price of $25.50 per share and the
                                payment of accrued dividends of $21.72 per
                                share. The pro forma entry consists of the
                                following:
<TABLE>
<CAPTION>
                                                                               Shares        Book Value
                                                                               ------        ----------
                                <S>                                            <C>              <C>
                                AHH Series B Preferred Stock converted into
                                  Common Stock subsequent to
                                  September 30, 1994                               28           $   765
                                Redemption of AHH Series B Preferred Stock
                                  plus accrued dividends                            1                47
                                                                                -----           -------
                                Total                                              29           $   812
                                                                                =====           =======
</TABLE>
           (11)                 To record the Merger using the purchase method
                                of accounting, including the adjustment of the
                                AHH's balance sheet to reflect the estimated
                                fair market value of its property based on
                                $0.9375 per share market price of AHH Common
                                Stock as of the Merger Agreement date. The
                                Merger Agreement does not specify the AHH Common
                                Stock market price to be used in the calculation
                                of the purchase price. The purchase price
                                allocation reflected in these pro forma
                                financial statements is based upon independent
                                appraisals of AHH's facilities obtained by AHH's
                                management prior to the Merger. For purposes of
                                allocation of the acquisition costs among the
                                various assets acquired, the Combined Company
                                has allocated the excess acquisition cost over
                                the carrying value of the acquired assets to
                                property, plant and equipment. Management does
                                not expect the final allocation of acquisition
                                costs to be materially different from that
                                assumed in the Pro Forma Combining Financial
                                Statements.

                                       14
<PAGE>   27
                  CHAMPION COMBINED GROUP AND AMERIHEALTH, INC.
                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

 Reference to Notes to Pro
     Forma Financial
        Statements              Explanations
 -------------------------      -----------------------------------------------
           (11)                 (Continued)

                                The following table summarizes the calculation
                                of the purchase price allocation (in thousands):
<TABLE>
                                <S>                                                      <C>            <C>
                                AmeriHealth, Inc. total common and common equivalent
                                  shares outstanding (a)                                                   19,180
                                Shares to be canceled                                                        (880)
                                                                                                        ---------
                                                                                                           18,300
                                Weighted average share price                                            $  0.9375
                                                                                                        ---------

                                Value of Common Stock                                                   $  17,156

                                Less proceeds from options assumed exercised                                 (699)

                                Plus cash paid for stock purchase                                             660
                                                                                                        ---------
                                                                                                           17,117

                                Plus:    estimated merger expenses                                          3,285
                                         long-term deferred tax liability recorded as a result of
                                          the merger                                                        5,405
                                Less:    short-term deferred tax asset recorded as a result of
                                          the merger                                                       (1,671)
                                         discount on RTC Loan                                                (384)
                                Less:    AmeriHealth, Inc. equity                        (6,705)
                                         Cash paid to redeem AHH Series B
                                          Preferred Stock and related accrued
                                          interest (See Note 9)                              47
                                         Cash dividend paid per AHH Common
                                          Stock share (See Note 9)                        1,462
                                                                                         ------

                                         Net AmeriHealth, Inc. equity                                      (5,196)
                                                                                                        ---------
                                         Total purchase price allocated to property &
                                           equipment                                                    $  18,556
                                                                                                        =========
</TABLE>

                                (a)   AmeriHealth, Inc. total common and common
                                      equivalent shares consist of the 
                                      following components as of September 30,
                                      1994:

<TABLE>
                                         <S>                                                            <C>
                                         Common shares outstanding                                         16,669
                                         Conversion of Series B Preferred Stock (29,100
                                           shares outstanding, 28,100 converted)                            1,405
                                         Options assumed exercised                                          1,106
                                                                                                        ---------
                                         AmeriHealth, Inc. total common and common
                                           equivalent shares outstanding                                   19,180
                                                                                                        =========
</TABLE>

                                       15
<PAGE>   28
                             CHAMPION COMBINED GROUP

                    PRO FORMA COMBINING FINANCIAL STATEMENTS

         The following Pro Forma Combining Balance Sheet as of September 30,
1994 and the Pro Forma Combining Income Statements for the nine months ended
September 30, 1994 and the year ended December 31, 1993 illustrate the effect of
the acquisition by the Company of Psychiatric Healthcare Corporation ("PHC") on
October 21, 1994. The Pro Forma Combining Balance Sheet assumes that the PHC
acquisition occurred on September 30, 1994 and the Pro Forma Combining Income
Statements assume that the PHC acquisition occurred at the beginning of the
earliest period presented and that the Company's acquisition of Midland
Physicians and Surgeons Hospital, Inc. ("MPS") on May 1, 1993 had occurred as of
January 1, 1993. Additionally, the Pro Forma Combining Income Statement for the
year ended December 31, 1993 assumes that PHC's acquisition of two psychiatric
facilities on April 13, 1993, had occurred as of January 1, 1993.

         The Company acquired the two operating and one closed psychiatric
hospitals of PHC by merger of PHC with and into a wholly-owned subsidiary of the
Company. The PHC acquisition was accounted for as a purchase transaction. Total
consideration issued to the PHC shareholders was approximately $12,000,000
(including a "contingent" consideration feature of up to $2,000,000) through the
issuance of a combination of Company Series D Preferred Stock and 11% Senior
Subordinated Notes with detachable Warrants and the assumption of $14,784,000 of
long-term debt. The contingent consideration will be issued if within the next
two years PHC receives up to $2,000,000 in payments from some combination of the
sale of the Sherman, Texas facility, the resolution of a Medicaid lawsuit
against the State of Missouri or the receipt by the Louisiana facility of more
than $500,000 in specified Medicaid and indigent payments. In March 1995, the
Company sold the Texas facility for approximately $1,300,000 to an unrelated
third party; accordingly, the Company expects to issue additional preferred
stock, notes and detachable warrants as required under the PHC purchase
agreement. Based on a preliminary allocation of the purchase price,
approximately $5,900,000 in excess purchase price has been assigned to goodwill,
which the Company will amortize over a period of 20 years.

         These Pro Forma Combining Financial Statements should be read in
conjunction with the historical financial statements of PHC, MPS and the Company
included in the definitive Proxy Statement of AmeriHealth, Inc., date November
11, 1994 and PHC's condensed consolidated financial statements for the nine
months ended September 30, 1994 (unaudited), included in the Company's report on
Form 8-K/A, Amendment No. 1, dated December 6, 1994.

         The Pro Forma Combining Financial Statements are presented for
comparative purposes only and are not intended to be indicative of actual
results had the transaction occurred as of the dates indicated above, nor do
they purport to indicate results which may be attained in the future.

                                       16
<PAGE>   29
     CHAMPION HEALTHCARE CORPORATION AND PSYCHIATRIC HEALTHCARE CORPORATION
                      PRO FORMA COMBINING INCOME STATEMENT
                  FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1994
                       (Thousands, except per share data)

<TABLE>
<CAPTION>
                                                                      Pro Forma                  Pro Forma
                                          Champion    Psychiatric    Adjustments    Reference     Combined
                                          --------    -----------    -----------    ---------    ---------
<S>                                       <C>           <C>           <C>            <C>         <C>
Total revenue                             $ 71,297      $18,442                                  $ 89,739

Expenses:
Salaries and benefits                       26,853        8,212                                    35,065
Supplies                                     9,163           --                                     9,163
Other operating expenses                    19,753        5,377                                    25,130
Provision for bad debts                      4,702        2,944                                     7,646
Interest                                     4,801        1,205            594         (1)          6,600
Depreciation and amortization                2,519          869            209         (2)          3,597
                                          --------      -------        -------                   --------

    Total expenses                          67,791       18,607            803                     87,201
                                          --------      -------        -------                   --------

    Income (loss) before taxes               3,506         (165)          (803)                     2,538

(Provision) benefit for income taxes          (248)          78            202         (3)             32
                                          --------      -------        -------                   --------

    Income (loss) from
      continuing operations                  3,258          (87)          (601)                     2,570

Adjustments to arrive at loss from
  continuing operations applicable
  to common stock                           (3,507)        (286)            (2)        (4)         (3,795)
                                          --------      -------        -------                   --------

    Loss from continuing
      operations applicable to
      common stock                        $   (249)     $  (373)       $  (603)                  $ (1,225)
                                          ========      =======        =======                   ========
    Loss from continuing
      operations per common
      and common equivalent
      share                               $  (0.21)                                              $  (1.01)
                                          ========                                               ========

Shares used in loss from continuing
  operations per common and
  common equivalent share
  computation (in thousands):                1,209                                                  1,209
                                          ========                                               ========
</TABLE>




See notes to pro forma combining financial statements (Champion Healthcare
Corporation, Midland Physicians and Surgeons Hospital, Inc. and Psychiatric
Healthcare Corporation).

                                       17
<PAGE>   30
CHAMPION HEALTHCARE CORPORATION, MIDLAND PHYSICIANS AND SURGEONS HOSPITAL, INC.
                     AND PSYCHIATRIC HEALTHCARE CORPORATION
                      PRO FORMA COMBINING INCOME STATEMENT
                      FOR THE YEAR ENDED DECEMBER 31, 1993
                       (Thousands, except per share data)

<TABLE>
<CAPTION>
                                               Physicians                    PHC          Pro Forma              Pro Forma
                                    Champion   & Surgeons  Psychiatric  Acquisition(8)   Adjustments  Reference   Combined
                                    --------   ----------  -----------  -----------      -----------  ---------  ---------
                                               (4 months)                (3 months &
                                                                           13 days)

<S>                                <C>           <C>         <C>          <C>              <C>        <C>        <C>
Total revenue                      $  89,832     $ 4,276     $20,058      $2,333                                 $116,499

Expenses:
Salaries and benefits                 36,698       2,034       9,486       1,294                                   49,512
Supplies                              11,641         361       6,760         125                                   18,887
Other operating expenses              24,033       1,651          --         944                                   26,628
Provision for bad debts                5,669         182       2,583         162                                    8,596
Interest                               2,725          95       1,146         390           $   959       (1)        5,315
Depreciation and
  amortization                         3,524         240         929         213               370       (2)        5,276
Asset write-down                      15,456          --          --         --                                    15,456
                                   ---------     -------     -------      ------           -------               --------

Total expenses                        99,746       4,563      20,904       3,128             1,329                129,670
                                   ---------     -------     -------      ------           -------               --------

Loss before taxes                     (9,914)       (287)       (846)       (795)           (1,329)               (13,171)

(Provision) benefit for
  income taxes                        (1,009)        104         278         271               326       (3)          (30)
                                   ---------     -------     -------      ------           -------               --------

Loss from continuing
  operations                         (10,923)       (183)       (568)       (524)           (1,003)               (13,201)


Adjustments to arrive at loss
  from continuing
  operations applicable to
  common stock                        (1,652)         --        (381)         --                (3)      (4)       (2,036)
                                   ---------     -------     -------      ------           -------               --------

  Loss from continuing
    operations applicable
    to common stock                $ (12,575)    $  (183)    $  (949)     $ (524)          $(1,006)              $(15,237)
                                   =========     =======     =======      ======           =======               ========

  Loss from continuing
    operations per
    common and
    common equivalent
    share                          $  (11.21)                                                                    $ (13.58)
                                   =========                                                                     ========

Shares used in loss from
  continuing operations per
  common and common
  equivalent share
  computation (in
  thousands):                          1,122                                                                        1,122
                                   =========                                                                     ========
</TABLE>

See notes to pro forma combining financial statements (Champion Healthcare
Corporation, Midland Physicians and Surgeons Hospital, Inc. and Psychiatric
Healthcare Corporation).

                                       18
<PAGE>   31
     CHAMPION HEALTHCARE CORPORATION AND PSYCHIATRIC HEALTHCARE CORPORATION
                       PRO FORMA COMBINING BALANCE SHEET
                               SEPTEMBER 30, 1994
                             (Dollars in thousands)

<TABLE>
<CAPTION>
                                                                         Pro Forma              Pro Forma
                                               Champion   Psychiatric   Adjustments  Reference   Combined
                                               --------   -----------   -----------  ---------  ---------
<S>                                            <C>          <C>          <C>           <C>      <C>
ASSETS:

CURRENT ASSETS:
  Cash and cash equivalents                    $ 56,822     $ 1,737      $   (341)      (5)     $ 58,218
  Accounts receivable, net                       18,237       3,880                               22,117
  Supplies inventory                              1,428          68                                1,496
  Other                                           2,703         611                                3,314
                                               --------     -------      --------               --------
    TOTAL CURRENT ASSETS                         79,190       6,296          (341)                85,145

PROPERTY AND EQUIPMENT, net                      32,792      12,432         3,377      (5)(6)     48,601

OTHER ASSETS:
  Deferred charges                                4,051          --                                4,051
  Goodwill                                           --                     5,900       (5)        5,900
  Other                                           2,607       1,160         1,300      (5)(6)      5,067
                                               --------     -------      --------               --------

    TOTAL ASSETS                               $118,640     $19,888      $ 10,236               $148,764
                                               ========     =======      ========               ========

LIABILITIES AND SHAREHOLDERS'
 EQUITY:

CURRENT LIABILITIES:
  Current portion of debt and capital lease
    obligations                                $  2,720     $13,052      $(12,370)      (7)     $  3,402
  Accounts payable                                6,002         800                                6,802
  Other current liabilities                       5,112         695                                5,807
                                               --------     -------      --------               --------

    TOTAL CURRENT LIABILITIES                    13,834      14,547       (12,370)                16,011
                                                                            1,200       (6)
                                                                            6,000       (5)
DEBT AND CAPITAL LEASE
 OBLIGATIONS                                     58,521       2,414        12,370       (7)       80,505

OTHER LONG-TERM LIABILITIES                       2,322          92         1,071       (5)        3,485

                                                                              800       (6)
                                                                            4,000       (5)
REDEEMABLE PREFERRED STOCK                       60,377       1,860        (1,860)      (5)       65,177

SHAREHOLDERS' EQUITY:
  Common Stock                                      151           1            (1)      (5)          151
  Additional paid-in capital                         --         530          (530)      (5)           --
  Retained deficit                              (16,565)        444          (444)      (5)      (16,565)
                                               --------     -------      --------               --------

    TOTAL SHAREHOLDERS' EQUITY                  (16,414)        975          (975)               (16,414)
                                               --------     -------      --------               --------

    TOTAL LIABILITIES AND
     SHAREHOLDERS' EQUITY                      $118,640     $19,888      $ 10,236               $148,764
                                               ========     =======      ========               ========
</TABLE>


See notes to pro forma combining financial statements (Champion Healthcare
Corporation, Midland Physicians and Surgeons Hospital, Inc. and Psychiatric
Healthcare Corporation).

                                       19
<PAGE>   32
 CHAMPION HEALTHCARE CORPORATION, MIDLAND PHYSICIANS AND SURGEONS HOSPITAL, INC.
                     AND PSYCHIATRIC HEALTHCARE CORPORATION

                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

         The following is a summary of pro forma adjustments by line item.

    Reference to Notes to 
     Pro Forma Financial 
          Statements            Explanations
    ---------------------       ------------------------------------------------
            (1)                 To record interest expense on the 11% Senior
                                Subordinated Notes assumed to be issued in the
                                acquisition of PHC and on the prior 10% Senior
                                Subordinated Notes assumed to be issued in the
                                acquisition of MPS.

            (2)                 To adjust depreciation expense based upon the
                                step up in basis for the depreciable assets of
                                PHC. The acquired assets are assumed to have
                                average remaining estimated useful lives of
                                approximately 22 and 17 years for PHC and MPS,
                                respectively. The allocation with respect to PHC
                                was based on an independent appraisal obtained
                                by the Company which resulted in the preliminary
                                allocation of approximately $5,900,000 of excess
                                purchase price to goodwill, which is being
                                amortized on a straight line basis using a
                                twenty year life. The allocation with respect to
                                MPS is based on management's assumption that an
                                acute care hospital's assets consist of 50%
                                buildings and 50% equipment with a 30 year life
                                and a 5 year life, respectively.

            (3)                 To reflect the pro forma provision for income
                                taxes due to the inclusion of the acquired
                                operations.

            (4)                 Pro forma adjustments to arrive at income
                                applicable to common stock consist of the
                                following:

<TABLE>
<CAPTION>
                                                                          September 30,         December 31,
                                                                              1994                  1993
                                                                              ----                  ----
                                         
                               <S>                                        <C>                    <C>
                               Dividend requirements of the Company
                                   Series D Preferred stock issued as
                                   acquisition consideration              $    (288)             $    (384)
                                                                          
                                                                               
                               Reversal of dividend requirements on
                                   PHC's Series A and Series B
                                   redeemable convertible Preferred
                                   Stock                                        286                    381
                                                                          ---------              ---------
                                                                          $      (2)             $      (3)
                                                                          =========              ========= 
</TABLE>






                                       20
<PAGE>   33



 CHAMPION HEALTHCARE CORPORATION, MIDLAND PHYSICIANS AND SURGEONS HOSPITAL, INC.
                     AND PSYCHIATRIC HEALTHCARE CORPORATION

                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS


    Reference to Notes to 
     Pro Forma Financial 
          Statements            Explanations
    ---------------------       ------------------------------------------------

            (5)                 To record the acquisition of PHC using the
                                purchase method of accounting, including the
                                adjustment of PHC's balance sheet to reflect the
                                estimated fair market value of its property and
                                equipment in excess of cost over fair value of
                                identified tangible assets. The purchase price
                                allocation reflected in the pro forma financial
                                statements is based on an independent appraisal
                                obtained by the Company which resulted in the
                                preliminary allocation of approximately
                                $5,900,000 of excess purchase price to goodwill.
                                It is management's intention to more fully
                                evaluate the acquired assets and, as a result,
                                the allocation of the acquisition costs among
                                the tangible and intangible assets acquired may
                                change. Management does not expect the final
                                allocation of acquisition costs to be materially
                                different from that assumed in the Pro Forma
                                Combining Financial Statements. The following
                                table summarizes the calculations of the
                                purchase price allocation:

<TABLE>
                                <S>                                                                   <C>
                                Value of 11% Senior Subordinated Notes issued as 
                                    consideration (including $1,200,000 in contingent 
                                    consideration - See Note 7)                                       $     7,200
                                Value of the Company's redeemable Series D Preferred Stock
                                    issued as consideration (including $800,000 in contingent
                                    consideration - See Note 7)                                             4,800
                                Deferred tax liability recorded as a result of the acquisition              1,071
                                Transaction costs                                                             341
                                Less:    PHC equity                                                         ( 975)
                                         PHC redeemable preferred stock                                    (1,860)
                                                                                                      ----------- 
                                                                                                           10,577
                                Less purchase price allocated to property and equipment based
                                    on a preliminary independent appraisal obtained by the
                                    Company.                                                               (3,377)
                                Less purchase price allocated to assets held for sale                      (1,300)
                                                                                                      ----------- 
                                Purchase price allocated to goodwill                                  $     5,900
                                                                                                      ===========
</TABLE>


            (6)                 To record up to an additional 44,494 shares of
                                Series D Preferred Stock ($800,000) and
                                $1,200,000 of 11% Senior Subordinated Notes with
                                35,820 detachable warrants the Company agreed to
                                issue if, within the next two years, PHC
                                receives up to $2 million from a combination of
                                sale of the Texas property, a recovery from a
                                lawsuit and certain specified Medicaid payments,
                                and to allocate the related cost to the
                                underlying assets. If amounts received are less
                                than $2 million, the securities issued will be
                                reduced proportionately. In March 1995, the
                                Company sold the Texas facility for
                                approximately $1,300,000 to an unrelated third
                                party; accordingly, the Company expects to issue
                                additional preferred stock, notes and detachable
                                warrants as required under the PHC purchase
                                agreement. The pro forma balance sheet reflects
                                the reclassification of $1,300,000 allocated to
                                the Texas facility which was held for sale and
                                included in other assets.



                                       21
<PAGE>   34



 CHAMPION HEALTHCARE CORPORATION, MIDLAND PHYSICIANS AND SURGEONS HOSPITAL, INC.
                     AND PSYCHIATRIC HEALTHCARE CORPORATION

                NOTES TO PRO FORMA COMBINING FINANCIAL STATEMENTS

    Reference to Notes to 
     Pro Forma Financial 
          Statements            Explanations
    ---------------------       ------------------------------------------------

            (7)                 To record the Company's pro forma assumption of
                                PHC's $12,970,000 mortgage note payable, less
                                the current portion of $600,000 at September 30,
                                1994. The PHC mortgage note payable was
                                classified as current because there was an event
                                of default arising from the closing of the
                                Sherman, Texas facility. Upon completion of the
                                PHC acquisition, the Company obtained a
                                permanent waiver from the lender as part of the
                                debt assumption; thus, the balance has been
                                reclassified to non-current.

            (8)                 To reflect the historical operating results for
                                the period from January 1, 1993 to April 12,
                                1993 of two psychiatric facilities acquired by
                                Psychiatric Healthcare Corporation on April 13,
                                1993.



                                       22


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission